Evidence map›Paper›PMID 38213149›Full record

ArticleRecent advances in anti-infective drug discovery2024

Investigation of

Iman Poladi, Pegah Shakib, Shahnaz Halimi, Somayeh Delfani, Farzad Ebrahim Zadeh, Faranak Rezaei

Abstract read
PubMed Publisher
In one paragraph

Article in Recent advances in anti-infective drug discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Iman PoladiSchool of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Pegah ShakibRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Shahnaz HalimiDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Somayeh DelfaniDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farzad Ebrahim ZadehNutritional Health Research Center, Department of Biostatistics and Epidemiology, School of Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran.
Faranak RezaeiRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Lorestan University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

Lorestan University of Medical Sciences, Lorestan, Iran 380
6 · The paper itself

Abstract

background

methodsIn this study, 79

resultsAmong 79

conclusionBased on the results, biofilm production and simultaneous presence of epsA, ompA, and bap genes among MDR, and XDR

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsBacterial Outer Membrane ProteinsBiofilmsDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsHumansIranMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsOMPA outer membrane proteinsAcinetobacter baumanniiantibiotic resistanceBiofilmclinical isolates.extensively drug-resistantmulti-drug resistance

Identifiers

PMID38213149
OpenAlexW4390792456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.